Human Vascular Endothelial Growth Factor receptor-2 Fc Chimera (VEGFR2 Fc) Enzyme

REQUEST MORE INFO
Catalogue No: abx073669
Price: US$261.00
(Size: 2 µg)

Click on the image to see the image legend

Available Options

* Size:



Add to Shopping Cart Buy It Now GET A QUOTE

Documents

Datasheet SDS
Human Vascular Endothelial Growth Factor receptor-2 Fc Chimera Protein is a recombinant protein kinase expressed in Insect cells.

Target Vascular Endothelial Growth Factor receptor-2 Fc Chimera (VEGFR2 Fc)
Origin Human
Expression Recombinant
Tested Applications SDS-PAGE
Host Insect
Recommended dilutions Optimal dilutions/concentrations should be determined by the end user.
Form Lyophilized
Purity > 90% (SDS-PAGE)
Purification Purified by proprietary chromatographic techniques.
Reconstitution Reconstitute in sterile water to a concentration of at least 50 µg/ml. This stock solution can be further diluted if required.
Storage Store dessicated at -20 °C for long-term storage. Upon reconstitution, store at 4 °C for up to 7 days and store below -18 °C for long-term storage. For long-term storage, it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid repeated freeze/thaw cycles.
Validity Stable at room temperature for up to 3 weeks.
UniProt Primary AC P35968 (UniProt, ExPASy)
UniProt Secondary AC A2RRS0, B5A925, C5IFA0, O60723, Q14178
UniProt Entry Name VGFR2_HUMAN
KEGG hsa:3791
String 9606.ENSP00000263923
Enzyme Commission Number EC:2.7.10.1
Molecular Weight 145 kDa
Sequence Fragment 968 AA. The soluble receptor protein contains only the first 7 extracellular domains, which is sufficient for ligand binding.
Sequence ASVGLPSVSL DLPRLSIQKD ILTIKANTTL QITCRGQRDL DWLWPNNQSG SEQRVEVTEC SDGLFCKTLT IPKVIGNDTG AYKCFYRETD LASVIYVYVQ DYRSPFIASV SDQHGVVYIT ENKNKTVVIP CLGSISNLNV SLCARYPEKR FVPDGNRISW DSKKGFTIPS YMISYAGMVF CEAKINDESY QSIMYIVVVV GYRIYDVVLS PSHGIELSVG EKLVLNCTAR TELNVGIDFN WEYPSSKHQH KKLVNRDLKT QSGSEMKKFL STLTIDGVTR SDQGLYTCAA SSGLMTKKNS TFVRVHEKPF VAFGSGMESL VEATVGERVR IPAKYLGYPP PEIKWYKNGI PLESNHTIKA GHVLTIMEVS ERDTGNYTVI LTNPISKEKQ SHVVSLVVYV PPQIGEKSLI SPVDSYQYGT TQTLTCTVYA IPPPHHIHWY WQLEEECANE PSQAVSVTNP YPCEEWRSVE DFQGGNKIEV NKNQFALIEG KNKTVSTLVI QAANVSALYK CEAVNKVGRG ERVISFHVTR GPEITLQPDM QPTEQESVSL WCTADRSTFE NLTWYKLGPQ PLPIHVGELP TPVCKNLDTL WKLNATMFSN STNDILIMEL KNASLQDQGD YVCLAQDRKT KKRHCVVRQL TVLERVAPTI  TGNLENQTTS IGESIEVSCT ASGNPPPQIM WFKDNETLVE DSGIVLKDGN RNLTIRRVRK EDEGLYTCQA CSVLGCAKVE AFFIIEGANA SDKTHTCPPC PAPELLGGPS VFLFPPKPKD TLMISRTPEV TCVVVDVSHE DPEVKFNWYV DGVEVHNAKT KPREEQYNST YRVVSVLTVL HQDWLNGKEY KCKVSNKALP APIEKTISKA KGQPREPQVY TLPPSREEMT KNQVSLTCLV KGFYPSDIAV EWESNGQPEN NYKTTPPMLD SDGSFFLYSK LTVDKSRWQQ GNVFSCSVMH EALHNHYTQK SLSLSPGK
Tag Recombinant Human Soluble VEGFR2 is fused with the Fc domain of Human IgG1.
Buffer Prior to lyophilization: 1X PBS, pH 7.2.
Biological Activity Inhibits the VEGF-dependent proliferation of Human umbilical vein endothelial cells.
Concentration Prior to lyophilization: 1 mg/ml
Availability Shipped within 5-10 working days.
Note This product is for research use only.

Not for human consumption, cosmetic, therapeutic or diagnostic use.
Research Articles on Vascular Endothelial Growth Factor receptor-2 Fc Chimera (VEGFR2 Fc)


Write a review

Tags:
(Click to show)